stock
CCCC · C4 Therapeutics, Inc.
What C4 Therapeutics, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live CCCC price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on CCCC.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 123,025,136 as of 2026-07-31 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -319.0%
- Net
- -289.4%
Returns
- ROE
- -41.0%
- ROA
- -28.2%
Health
- Current ratio
- 5.4x
- Debt/equity
- —
Deep value
- NCAV
- $150.76M
- NCAV per share
- $1.23
- Price/NCAV
- Locked
- NNWC
- -$32.53M
- NNWC per share
- -$0.26
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $6.64M | —Gross profit: unreported by this company. | -$26.42M | -$23.64M | 10-Q filed 2026-08-11 |
| 2026-03-31 | $6.15M | —Gross profit: unreported by this company. | -$27.79M | -$25.13M | 10-Q filed 2026-08-11 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $11.02M | —Gross profit: unreported by this company. | -$23.14M | -$20.49M | DEF 14A filed 2026-04-29 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $11.23M | —Gross profit: unreported by this company. | -$34.41M | -$32.17M | 10-Q filed 2025-11-06 |
| 2025-06-30 | $6.46M | —Gross profit: unreported by this company. | -$28.50M | -$26.02M | 10-Q filed 2026-08-11 |
| 2025-03-31 | $7.24M | —Gross profit: unreported by this company. | -$29.16M | -$26.32M | 10-Q filed 2026-08-11 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $5.18M | —Gross profit: unreported by this company. | -$37.71M | -$34.57M | DEF 14A filed 2026-04-29 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $15.36M | —Gross profit: unreported by this company. | -$28.24M | -$24.67M | 10-Q filed 2025-11-06 |
- Assets
- $359.40M
- Equity
- $247.26M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $35.95M | -$115.22M | -$104.99M | -$99.30M |
| 2024-12-31 | $35.58M | -$119.61M | -$105.32M | -$65.34M |
| 2023-12-31 | $20.76M | -$139.03M | -$132.49M | -$108.55M |
| 2022-12-31 | $31.10M | -$129.53M | -$128.18M | -$111.44M |
| 2021-12-31 | $45.78M | -$82.13M | -$83.89M | -$88.24M |
| 2020-12-31 | — | -$60.45M | -$66.33M | -$67.90M |
| 2019-12-31 | — | -$35.45M | -$34.10M | $54.27M |
Company filings
since Fri Nov 21 · 2 offering filings in 12 months · since Wed Dec 10
events
Regulation FD disclosure, Other event
Regulation FD disclosureOther eventSep 258-KResults
ResultsAug 118-KShareholder vote results
Shareholder vote resultsJun 248-KRegulation FD disclosure, Other event
Regulation FD disclosureOther eventJun 118-KExecutive or director change
Executive or director changeMay 158-KResults, Regulation FD disclosure
ResultsRegulation FD disclosureMay 128-K
5% owners ()
RA Capital Management, L.P.
Stake update
Lynx1 Capital Management LP
Stake update
Squadron Master Fund LP
Stake update
Morgan Stanley
Stake update
BlackRock, Inc.
Passive stake
Insiders, politicians and funds
Insider trades, last 90 days
Couldn’t load insider trades
This read is unavailable. Try it again without changing anything on the page.
Politician trades, last 90 days
Couldn’t load politician trades
This read is unavailable. Try it again without changing anything on the page.
Funds
Couldn’t load funds
This read is unavailable. Try it again without changing anything on the page.
News
Stories that named CCCC, and the market events around them.
Sign in to see thisBoard
The CCCC board could not be loaded.
Retry the CCCC boardnakagai
Signals on CCCC come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the CCCC board